These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6743931)

  • 41. Sleep-onset rapid eye movement after electroconvulsive therapy is more frequent in patients who respond less well to electroconvulsive therapy.
    Grunhaus L; Shipley JE; Eiser A; Pande AC; Tandon R; Krahn DD; Demitrack MA; Remen A; Hirschmann S; Greden JF
    Biol Psychiatry; 1997 Aug; 42(3):191-200. PubMed ID: 9232211
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prediction of the utility of a switch from unilateral to bilateral ECT in the elderly using treatment 2 ictal EEG indices.
    Krystal AD; Holsinger T; Weiner RD; Coffey CE
    J ECT; 2000 Dec; 16(4):327-37. PubMed ID: 11314870
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serum prolactin, electrode placement, and the convulsive threshold during ECT.
    McCall WV; Weiner RD; Carroll BJ; Shelp FE; Ritchie JC; Austin S; Norris J
    Convuls Ther; 1996 Jun; 12(2):81-5. PubMed ID: 8744166
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Who responds to electroconvulsive therapy? A comparison of effective and ineffective forms of treatment.
    Sobin C; Prudic J; Devanand DP; Nobler MS; Sackeim HA
    Br J Psychiatry; 1996 Sep; 169(3):322-8. PubMed ID: 8879718
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Blood concentrations of vasopressin, neuropeptide FF and prolactin are increased by high-dose right unilateral ECT.
    Sundblom DM; Heikman P; Naukkarinen H; Fyhrquist F
    Peptides; 1999; 20(3):319-26. PubMed ID: 10447089
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prolactin and beta-endorphin serum elevations after ECT in manic patients.
    Chaudhry HR; Hofmann P; Loimer N; Kotter M; Quehenberger F; Fueger G
    Acta Psychiatr Scand; 2000 Nov; 102(5):386-9. PubMed ID: 11098811
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neuroendocrine evidence for increased responsiveness of dopamine receptors in humans following electroconvulsive therapy.
    Balldin J; Granérus AK; Lindstedt G; Modigh K; Wålinder J
    Psychopharmacology (Berl); 1982; 76(4):371-6. PubMed ID: 6812112
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prolactin changes during electroconvulsive therapy: A systematic review and meta-analysis.
    Schoretsanitis G; Cicek M; Mathur N; Sanghani SN; Kane JM; Petrides G
    J Psychiatr Res; 2020 Sep; 128():25-32. PubMed ID: 32516627
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Postictal suppression correlates with therapeutic efficacy for depression in bilateral sine and pulse wave electroconvulsive therapy.
    Azuma H; Fujita A; Sato K; Arahata K; Otsuki K; Hori M; Mochida Y; Uchida M; Yamada T; Akechi T; Furukawa TA
    Psychiatry Clin Neurosci; 2007 Apr; 61(2):168-73. PubMed ID: 17362434
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Response of depressed patients to sequential unilateral nondominant brief-pulse and bilateral sinusoidal ECT.
    Price TR; McAllister TW
    J Clin Psychiatry; 1986 Apr; 47(4):182-6. PubMed ID: 3957877
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Use of electroconvulsive therapy in adolescence].
    Paillère-Martinot ML; Zivi A; Basquin M
    Encephale; 1990; 16(5):399-404. PubMed ID: 1979944
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Naloxone has no effect on hormonal responses to ECT in man.
    Turner TH; Ur E; Grossman A
    Psychiatry Res; 1987 Nov; 22(3):207-12. PubMed ID: 2829259
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dexamethasone in electroconvulsive therapy: efficacy for depression and post-ECT amnesia.
    Horne RL; Pettinati HM; Menken M; Sugerman AA; Varga E; Wilson GF
    Biol Psychiatry; 1984 Jan; 19(1):13-27. PubMed ID: 6704458
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Decreased efficacy of combined benzodiazepines and unilateral ECT in treatment of depression.
    Jha A; Stein G
    Acta Psychiatr Scand; 1996 Aug; 94(2):101-4. PubMed ID: 8883570
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serotonergic mechanisms of ECT: neuroendocrine evidence.
    Shapira B; Newman M; Lerer B
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():673A-674A. PubMed ID: 1498996
    [No Abstract]   [Full Text] [Related]  

  • 56. Generalization of the effects of unilateral and bilateral ECT.
    Swartz CM; Larson G
    Am J Psychiatry; 1986 Aug; 143(8):1040-1. PubMed ID: 3728721
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Studies on the prolactin response induced by electroconvulsive therapy in schizophrenics.
    Arató M; Erdós A; Kurcz M; Vermes I; Fekete M
    Acta Psychiatr Scand; 1980 Mar; 61(3):239-44. PubMed ID: 7376927
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy of ultrabrief pulse electroconvulsive therapy for depression: a systematic review.
    Spaans HP; Kho KH; Verwijk E; Kok RM; Stek ML
    J Affect Disord; 2013 Sep; 150(3):720-6. PubMed ID: 23790557
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Delusional depression, hyperparathyroidism, and ECT.
    Cunningham SJ; Anderson DN
    Convuls Ther; 1995 Jun; 11(2):129-33. PubMed ID: 7552053
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A dissociation between anterograde and retrograde amnesia after treatment with electroconvulsive therapy: a naturalistic investigation.
    O'Connor M; Lebowitz BK; Ly J; Panizzon MS; Elkin-Frankston S; Dey S; Bloomingdale K; Thall M; Pearlman C
    J ECT; 2008 Jun; 24(2):146-51. PubMed ID: 18580560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.